CN Patent

CN101541788A — 作为激酶抑制剂的化合物和组合物

Assigned to IRM LLC · Expires 2009-09-23 · 17y expired

What this patent protects

本发明提供了一类新的化合物、含有这类化合物的药物组合物以及使用这类化合物治疗或预防疾病或障碍的方法，所述疾病或障碍与激酶活性的异常或失调、尤其是与TrkA、TrkB、TrkC、PDGFR和c－kit的异常或失调有关。

USPTO Abstract

本发明提供了一类新的化合物、含有这类化合物的药物组合物以及使用这类化合物治疗或预防疾病或障碍的方法，所述疾病或障碍与激酶活性的异常或失调、尤其是与TrkA、TrkB、TrkC、PDGFR和c－kit的异常或失调有关。

Drugs covered by this patent

Patent Metadata

Patent number
CN101541788A
Jurisdiction
CN
Classification
—
Expires
2009-09-23
Drug substance claim
No
Drug product claim
No
Assignee
IRM LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.